Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-894 in diabetic neuropathic pain
NCT00548925Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of sofinicline in diabetic neuropathy, sponsored by AbbVie Inc.. Started Nov 2007; status: completed.
02
Drugs
sofinicline
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00548925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548925.